Krystal Biotech, Inc. (KRYS)
261.41
+12.50
(+5.02%)
USD |
NASDAQ |
Jan 09, 16:00
261.38
-0.03
(-0.01%)
After-Hours: 20:00
Krystal Biotech Research and Development Expense (Quarterly): 13.18M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| DexCom, Inc. | 157.50M |
| BioLife Solutions, Inc. | 2.709M |
| Alnylam Pharmaceuticals, Inc. | 358.81M |
| Catalyst Pharmaceuticals, Inc. | 2.657M |
| Amicus Therapeutics, Inc. | 23.42M |